The Antibodies Market is experiencing substantial demand from oncology applications. Market Research Future identifies oncology as the largest application segment, accounting for approximately 49% of the market.

Antibody-based therapies have become an important component of modern cancer treatment. Monoclonal antibodies can be designed to recognize specific proteins or markers associated with cancer cells, supporting targeted treatment strategies.

Antibody-drug conjugates are another area of innovation. These therapies combine antibody targeting capabilities with therapeutic payloads, creating opportunities for more selective delivery of medicines.

The oncology pipeline continues to expand as pharmaceutical and biotechnology companies investigate new targets and therapeutic combinations. Research is also exploring ways to improve treatment effectiveness and address resistance.

As cancer incidence and demand for advanced therapies increase, oncology is expected to remain a major contributor to the global antibodies market.